Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 593008
                    [Title] => Novartis osteoporosis treatment surpasses 1-millionth infusion
                    [Summary] => 
More than one million patients around the world have received the breakthrough Novartis anti-osteoporosis treatment intravenous zoledronic acid.
                    [DatePublished] => 2010-07-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

TIMELESS MOMENTS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 593008
                    [Title] => Novartis osteoporosis treatment surpasses 1-millionth infusion
                    [Summary] => 
More than one million patients around the world have received the breakthrough Novartis anti-osteoporosis treatment intravenous zoledronic acid.
                    [DatePublished] => 2010-07-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis osteoporosis treatment surpasses 1-millionth infusion

July 15, 2010 - 12:00am

More than one million patients around the world have received the breakthrough Novartis anti-osteoporosis treatment intravenous zoledronic acid.

Science and Environment